CClinicalTrials.gg
TerminatedNCT03895125Updated Feb 13, 2020

The Learning Effects of Attentional Strategy on Dual-task Walking in Patients With Parkinson's Disease: Behavioral Performance and Neural Plasticity

An interventional study of [year1] dual-task training with task priority strategy and [year2-3] dual-task training with internal and external focus in Parkinson Disease, sponsored by National Taiwan University Hospital. Terminated at 1 site in Taiwan. Open to participants aged 40 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-02-13.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment

Why this study was terminated
Study halted prematurely and will not resume
Phase
Not applicable
Study type
Interventional
Enrollment
1
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Study summary

[year1]

  1. To compare the effects of dual-task training with two different task priority instruction in people with Parkinson's disease and healthy controls on dual-task weight shifting performances.
  2. Investigate the changes of brain activities and functional connectivity after dual-task training with different task priority instructions.

[year 2-3]

To investigate the learning effects of walking with internal/external focus on walking automaticity and brain plasticity in dual-task walking training for PD patients with/without freezing of gait.

Read the detailed description

Postural-suprapostural task is defined as postural control takes place while another concurrent task is being performed, belonging to dual-task paradigms. Effective dual-task training is important to patients with Parkinson disease (PD), because they often lose balance and fall in dual-task conditions. Attentional strategy includes 1) task-priority between postural and suprapostural tasks and 2) internal and external focus for the postural task, which is the critical factor for both dual-task control and motor learning. However, the appropriateness of attentional strategy has not been investigated in dual-task training in patients with PD. Besides, there is lack of neural evidence of brain plasticity for previous studies about dual-task training in patients with PD. With the uses of EEG, EMG and behavioral measures, the purpose of this 3-year research project is to investigate the differences in performance quality and intrinsic neural mechanisms of dual-task training in PD, by adopting task-priority strategy and internal/external strategy during weight-shifting and walking. In the first year, the investigators will characterize task-priority effect (posture-priority vs. supraposture-priority) on dual-task training, with a special focus on modulation of brain plasticity and muscle activity patterns in weight-shifting posture for patients with PD. In the second and third years, the learning effects of walking internal/external focus on walking automaticity and brain plasticity will be investigated in dual-task walking training for PD patients with/without freezing of gait. Besides, the transfer effects of dual-task learning will be also investigated on medication "off" state. The present project is expected to have significant contributions not only to gain a better insight to neural correlates of dual-task training with different attentional strategies under weight-shifting and walking, but to optimize treatment strategy for PD patients with balance or dual-tasking disturbances.

02

Conditions studied

  • Parkinson Disease

Browse trials for

Keywords

  • dual-task training
  • attention
  • Parkinson's disease
  • walking
  • EEG
03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

This study's enrollment of 1 is below the median of 40 across 3,294 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

[year1]

Inclusion criteria:

  1. For people with Parkinson's disease

    1. modified Hoehn \& Yahr stage 2-3
    2. without dementia and able to follow instructions
  2. For healthy controls

age and gender matched healthy subjects as control group

Exclusion criteria:

  1. MMSE \< 26
  2. with other disease that may influence balance ability
  3. with marked action and postural tremor

[year2-3] inclusion criteria:

  1. idiopathic Parkinson's disease
  2. modified Hoehn \& Yahr stage 2-3
  3. without marked action or postural tremor

exclusion criteria:

  1. MMSE \< 26
  2. with other disease that may influence balance ability
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
1 participant (actual)

Study arms

  • Experimental
    [year1] PD group

    Behavioral: [year1] dual-task training with task priority strategy

  • Active comparator
    [year1] healthy control group

    Behavioral: [year1] dual-task training with task priority strategy

  • Experimental
    [year2-3] freezer

    Behavioral: [year2-3] dual-task training with internal and external focus

  • Experimental
    [year2-3] non-freezer

    Behavioral: [year2-3] dual-task training with internal and external focus

Interventions

  • Behavioral[year1] dual-task training with task priority strategy

    postural focus: focus mainly on postural performances while dual-tasking suprapostural focus: focus mainly on suprapostural performances while dual-tasking

  • Behavioral[year2-3] dual-task training with internal and external focus

    internal focus: focus mainly on body movements external focus: focus mainly on object in the environment

06

What researchers measure

Primary outcomes

  1. postural performance

    measuring the amount of body weight shifting (unit: kg)

    Time frame: about 36 seconds for each trial for a total of 25 minutes

  2. suprapostural performance

    measuring the rotation angle of box on the hand (unit: degree)

    Time frame: about 36 seconds for each trial for a total of 25 minutes

  3. Walking speed

    collecting by using the GAITRite electronic walkway (CIR systems, Inc. ,USA) 24 inches(61cm) wide and 192 inches (488cm, 16ft) long, total 18,432 sensor (unit: m/s)

    Time frame: about 10-20 seconds for each trial

  4. Cadence

    collecting by using the GAITRite (unit: step/s)

    Time frame: about 10-20 seconds for each trial

  5. Gait symmetry

    collecting single leg supporting time of right and left leg by using the GAITRite

    Time frame: about 10-20 seconds for each trial

Secondary outcomes

  1. electroencephalography (EEG)

    to collect the brain activity (unit: uV)

    Time frame: about 36 seconds for each trial for a total of 25 minutes

  2. electromyography (EMG)

    to collect the muscle activity (unit: mV)

    Time frame: about 36 seconds for each trial for a total of 25 minutes

07

Study locations

1 site
  • National Taiwan University Hospital
    Taipei, 10048, Taiwan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 13, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03895125
Lead sponsor
National Taiwan University Hospital
Responsible party
Sponsor
First posted
Mar 29, 2019
Start date
Mar 7, 2019
Primary completion
Feb 12, 2020
Completion
Feb 12, 2020
Last update
Feb 13, 2020

Study contacts

Cheng-Ya Huang
principal investigator · School & Graduate Institute of Physical Therapy, College of Medicine, National Taiwan University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion